Lasse Lehtonen

Myocardial efficiency during levosimendan infusion in congestive heart failure

H. Iida, K. Någren, J. Knuuti, 2000, Clinical pharmacology and therapeutics.

Site dependent bioavailability and metabolism of levosimendan in dogs.

H. Kanerva, T. Nevalainen, P. Vanninen, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.

L. Lehtonen, M. Kivikko, Lasse Lehtonen, 2005, Current pharmaceutical design.

Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function.

M. Viitasalo, L. Toivonen, L. Lehtonen, 2000, Journal of cardiovascular pharmacology.

Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure.

P. Heikkinen, E. Sandell, L. Lehtonen, 1995, Journal of cardiovascular pharmacology.